Literature DB >> 23824601

Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects.

Sadia Saeed1, Paul R Bech, Tayyaba Hafeez, Rabail Alam, Mario Falchi, Mohammad A Ghatei, Stephen R Bloom, Muhammad Arslan, Philippe Froguel.   

Abstract

Congenital leptin deficiency, a rare genetic disorder due to a homozygous mutation in the leptin gene (LEP), is accompanied by extreme obesity and hyperphagia. A number of gastrointestinal hormones have been shown to critically regulate food intake but their physiological role in hyperphagic response in congenital leptin deficiency has not been elucidated. This study is the first to evaluate the fasting and postprandial profiles of gut-derived hormones in homozygous and heterozygous carriers of LEP mutation. The study subjects from two consanguineous families consisted of five homozygous and eight heterozygous carriers of LEP mutation, c.398delG. Ten wild-type normal-weight subjects served as controls. Fasting and 1-h postprandial plasma ghrelin, glucagon-like peptide (GLP) 1, peptide YY (PYY), leptin and insulin levels were measured by immunoassays. Fasting plasma ghrelin levels in homozygotes remained remarkably unchanged following food consumption (P = 0.33) in contrast to a significant decline in heterozygous (P < 0.03) and normal (P < 0.02) subjects. A significant postprandial increase in PYY was observed in heterozygous (P < 0.02) and control subjects (P < 0.01), but not in the homozygous group (P = 0.22). A postprandial rise in GLP-1 levels was significant (P < 0.02) in all groups. Interestingly, fasting leptin levels in heterozygotes were not significantly different from controls and did not change significantly following meal. Our results demonstrate that gut hormones play little or no physiological role in driving the hyperphagic response of leptin-deficient subjects. In contrast, fasting and postprandial levels of gut hormones in heterozygous mutation carriers were comparable to those of normal-weight controls.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23824601     DOI: 10.1007/s12020-013-0009-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  44 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 2.  Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity.

Authors:  Ashwini Oswal; Giles Yeo
Journal:  Obesity (Silver Spring)       Date:  2009-07-30       Impact factor: 5.002

3.  In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.

Authors:  Louise Purtell; Lisa Sze; Georgina Loughnan; Ellie Smith; Herbert Herzog; Amanda Sainsbury; Katharine Steinbeck; Lesley V Campbell; Alexander Viardot
Journal:  Neuropeptides       Date:  2011-07-01       Impact factor: 3.286

4.  Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice.

Authors:  Yuxiang Sun; Mark Asnicar; Pradip K Saha; Lawrence Chan; Roy G Smith
Journal:  Cell Metab       Date:  2006-05       Impact factor: 27.287

5.  Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity.

Authors:  Bulent O Yildiz; Marc A Suchard; Ma-Li Wong; Samuel M McCann; Julio Licinio
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

6.  Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.

Authors:  K Zwirska-Korczala; S J Konturek; M Sodowski; M Wylezol; D Kuka; P Sowa; M Adamczyk-Sowa; M Kukla; A Berdowska; J F Rehfeld; W Bielanski; T Brzozowski
Journal:  J Physiol Pharmacol       Date:  2007-03       Impact factor: 3.011

Review 7.  Investigation of Mendelian forms of obesity holds out the prospect of personalized medicine.

Authors:  Alexandra I F Blakemore; Philippe Froguel
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

8.  Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity.

Authors:  Akila De Silva; Stephen R Bloom
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

Review 9.  Leptin signaling.

Authors:  Rexford S Ahima; Suzette Y Osei
Journal:  Physiol Behav       Date:  2004-04

10.  Effects of PYY[3-36] in rodent models of diabetes and obesity.

Authors:  R A Pittner; C X Moore; S P Bhavsar; B R Gedulin; P A Smith; C M Jodka; D G Parkes; J R Paterniti; V P Srivastava; A A Young
Journal:  Int J Obes Relat Metab Disord       Date:  2004-08
View more
  7 in total

1.  Screening of 31 genes involved in monogenic forms of obesity in 23 Pakistani probands with early-onset childhood obesity: a case report.

Authors:  Robina Khan Niazi; Anette Prior Gjesing; Mette Hollensted; Christian Theil Have; Dmitrii Borisevich; Niels Grarup; Oluf Pedersen; Asmat Ullah; Gulbin Shahid; Ifrah Shafqat; Asma Gul; Torben Hansen
Journal:  BMC Med Genet       Date:  2019-09-05       Impact factor: 2.103

2.  Prevalence estimates of putatively pathogenic leptin variants in the gnomAD database.

Authors:  Luisa Sophie Rajcsanyi; Yiran Zheng; Pamela Fischer-Posovszky; Martin Wabitsch; Johannes Hebebrand; Anke Hinney
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

3.  Monogenic forms of childhood obesity due to mutations in the leptin gene.

Authors:  Jan-Bernd Funcke; Julia von Schnurbein; Belinda Lennerz; Georgia Lahr; Klaus-Michael Debatin; Pamela Fischer-Posovszky; Martin Wabitsch
Journal:  Mol Cell Pediatr       Date:  2014-09-04

4.  The p. N103K mutation of leptin (LEP) gene and severe early onset obesity in Pakistan.

Authors:  Shahida Hasnain
Journal:  Biol Res       Date:  2016-04-13       Impact factor: 5.612

5.  Estimated prevalence of potentially damaging variants in the leptin gene.

Authors:  Adriana Nunziata; Guntram Borck; Jan-Bernd Funcke; Katja Kohlsdorf; Stephanie Brandt; Anke Hinney; Barbara Moepps; Peter Gierschik; Klaus-Michael Debatin; Pamela Fischer-Posovszky; Martin Wabitsch
Journal:  Mol Cell Pediatr       Date:  2017-11-03

Review 6.  When Leptin Is Not There: A Review of What Nonsyndromic Monogenic Obesity Cases Tell Us and the Benefits of Exogenous Leptin.

Authors:  Kaio Cezar Rodrigues Salum; Jônatas de Mendonça Rolando; Verônica Marques Zembrzuski; João Regis Ivar Carneiro; Cicero Brasileiro Mello; Clarissa Menezes Maya-Monteiro; Patrícia Torres Bozza; Fabiana Barzotto Kohlrausch; Ana Carolina Proença da Fonseca
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-24       Impact factor: 5.555

7.  Identification of novel LEPR mutations in Pakistani families with morbid childhood obesity.

Authors:  Robina Khan Niazi; Anette P Gjesing; Mette Hollensted; Christian Theil Have; Niels Grarup; Oluf Pedersen; Asmat Ullah; Gulbin Shahid; Wasim Ahmad; Asma Gul; Torben Hansen
Journal:  BMC Med Genet       Date:  2018-11-15       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.